Global Platelet-Rich Plasma Market: Prospects & Upcoming Trends and Opportunities Analyzed for Coming Years

The Global Platelet-rich Plasma Market was valued at US$ 195.2 Mn in 2017 and is projected to expand at a CAGR of 12.0% from 2018 to 2026 to reach US$ 543.5 Mn by 2026.

Logo

Albany, NY -- (SBWire) -- 10/05/2018 --A fresh report has been added to the wide database of Market Research Report Search Engine (MRRSE). The research study is titled "Global Platelet-rich Plasma Market: Prospects & Upcoming Trends and Opportunities Analyzed for Coming Years" which encloses important data about the production, consumption, revenue and market share, merged with information related to the market scope and product overview.

The global platelet-rich plasma market is growing at a rapid pace due rise in the percentage of orthopedic and sports injuries, increase in the number of cosmetic surgical procedures, and surge in adoption about platelet-rich plasma therapies in the treatment of various chronic as well as acute disorders across the globe. The market was valued at US$ 195.2 Mn in 2017 and is projected to expand at a CAGR of 12.0% from 2018 to 2026 to reach US$ 543.5 Mn by 2026. The global platelet-rich plasma market is driven by a surge in adoption of technologically advanced products and high prevalence of osteoarthritis, rheumatoid arthritis, juvenile arthritis, and other disorders.

To Get Sample Copy of Report, Click here @ https://www.mrrse.com/sample/2360

This report studies the current as well as future prospects of the global platelet-rich plasma market. Stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, and provision of platelet-rich plasma and new entrants planning to enter the market. This report comprises an elaborate executive summary along with a market snapshot providing overall information on various segments considered in the scope of the study. This section also provides the overall information and data analysis of the global platelet-rich plasma market regarding leading segments based on type, origin, application, and region.

The global platelet-rich plasma market has been segmented based on type, origin, application, and region. In terms of type, the global market has been classified into pure platelet-rich plasma, leukocyte-rich platelet-rich plasma, and pure platelet-rich fibrin. Based on origin, the global platelet-rich plasma market has been categorized into autologous platelet-rich plasma, allogeneic platelet-rich plasma, and homologous platelet-rich plasma. In terms of application, the global market has been divided into orthopedic surgery, neurosurgery, cosmetic surgery, general surgery, and others.

The market revenue for each type was estimated using a bottom-up approach. The revenue generated by each type and application has been calculated considering sales, usage data, and pattern in different regions. The bottom-up approach for determining the country market size was studied using various market indicators obtained from secondary sources, which include different types and origin of platelet-rich plasma and their cost variations in major country/region; prevalence and incidence in major countries for orthopedic disorders, sports injuries, arthritis, and other major diseases, and other treatments such as cosmetic surgeries and plastic surgeries for which platelet-rich plasma is used. Revenues of all publicly listed market players were obtained through secondary sources and analyzed for platelet-rich plasma systems specific revenues by narrowing down to revenue percentage for product segment through extensive secondary analysis of annual reports, investor presentations, press releases, primary interviews, and others. Data triangulation is based on secondary research (top-down and bottom-up approaches) and primary research. Moreover, historical year-on-year growth has been taken into consideration while estimating the market size. The market size and forecast in terms of US$ Mn for each segment has been provided for the period from 2016 to 2026. The report also provides the compound annual growth rate (CAGR %) for each segment for the forecast period from 2018 to 2026, considering 2017 as the base year.
The market overview section of the report explores market dynamics such as drivers, restraints, opportunities, and key trends that have a strong impact on the platelet-rich plasma market and could influence it in the near future. Market attractiveness analysis has been provided to explain the intensity of competition across different regions. The competitive scenario among different players is evaluated through market share analysis in the competitive landscape section of the report. These factors are likely to help market players take strategic decisions to strengthen their positions and expand their shares in the global platelet-rich plasma market.

Browse Complete Report with TOC @ https://www.mrrse.com/platelet-rich-plasma-market

In terms of region, the global platelet-rich plasma market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The report also provides market size and forecast for major countries with each product and distribution channel in the respective region. A detailed qualitative analysis of the factors responsible for driving and restraining the market and future opportunities have been provided in the overview section. This section of the report also provides the market attractiveness analysis and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global platelet-rich plasma market.

Major players operating in the global platelet-rich plasma market are Harvest Technologies Corp. (Terumo Corporation), Arthrex, Inc., Zimmer Biomet Holdings, Inc., EmCyte Corporation, Regen Lab SA, Exactech, Inc., and Cesca Therapeutics, Inc., Nuo Therapeutics, Inc., DePuy Synthes (Johnson & Johnson), ISTO Biologics, and AdiStem Ltd.

The global platelet-rich plasma market has been segmented as follows:

Global Platelet-rich Plasma Market, by Type

Pure Platelet-rich Plasma

Leukocyte-rich Platelet-rich Plasma

Pure Platelet-rich Fibrin

Global Platelet-rich Plasma Market, by Origin

Autologous Platelet-rich Plasma

Allogeneic Platelet-rich Plasma

Homologous Platelet-rich Plasma

Global Platelet-rich Plasma Market, by Application

Orthopedic Surgery

Neurosurgery

Cosmetic Surgery

General Surgery

Others

Global Platelet-rich Plasma Market, by Region

North America

The U.S.

Canada

Europe

Germany

U.K.

France

Italy

Spain

Rest of Europe

Asia Pacific

China

India

Japan

Australia & New Zealand

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of Middle East & Africa

Enquire about this Report @ https://www.mrrse.com/enquiry/2360

About Market Research Reports Search Engine (MRRSE)
Market Research Reports Search Engine (MRRSE) is an industry-leading database of Market Research Reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE's repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact Us

State Tower
90, State Street
Suite 700
Albany, NY – 12207
United States Telephone: +1-518-730-0559
Email: sales@mrrse.com
Website: https://www.mrrse.com/

Media Relations Contact

Himanshu
Manager
MRRSE
1-518-621-2074
https://www.mrrse.com/

View this press release online at: http://rwire.com/1057775